Advances, Limitations and Future Challenges in the Management of Immunotherapy for Hematological Diseases and Solid Tumors
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24108812 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Pierre Tennstedt und 1 weiteren Autor:innen. Beteiligte Einrichtung: Martini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany. Hauptthemen laut MEDLINE: Neoplasms, Hematologic Diseases. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Our immune system is able to attack cancer cells by recognizing cellular mistakes and destroying them [...]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Martini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.
ORCID-Profile: Pierre Tennstedt, Su Jung Oh-Hohenhorst
Zitieren
APA
Tennstedt, P., & Oh-Hohenhorst, S. J. (2023). Advances, Limitations and Future Challenges in the Management of Immunotherapy for Hematological Diseases and Solid Tumors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24108812
Vancouver
Tennstedt P, Oh-Hohenhorst SJ. Advances, Limitations and Future Challenges in the Management of Immunotherapy for Hematological Diseases and Solid Tumors. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24108812
BibTeX
@article{Tennstedt2023,
author = {Tennstedt, Pierre and Oh-Hohenhorst, Su Jung},
title = {Advances, Limitations and Future Challenges in the Management of Immunotherapy for Hematological Diseases and Solid Tumors},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24108812}
}
EUVIMED